Trial Profile
AVANDIA CV Outcomes Study: Thiazolidinedione Intervention With Vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular Disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Rosiglitazone (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms TIDE
- Sponsors GlaxoSmithKline; GSK
- 06 Apr 2022 This trial has been completed in Netherland (Global end date: 22/11/2010), according to European Clinical Trials Database record.
- 14 May 2019 This trial has been completed in Finland.
- 19 Nov 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.